H.C. Wainwright initiated coverage of Picard Medical with a Neutral rating without a price target. Picard is a holding company that owns 100% of SynCardia Systems, the manufacturer of the SynCardia Total Artificial Heart, the analyst tells investors in a research note. The firm says the company received a written notice on May 8 from the NYSE American indicating it is not in compliance with the continued listing standards.
